Archived Medical News Stories

RSSArchived Pharmaceutical News Stories - February 2010

Date Title Comments Rating
2010-02-27 Blacks less likely to know they have atrial fibrillation or about use of warfarin 0 None
2010-02-27 Single submission of orphan drug designation annual report for both FDA and EMA 0 2
2010-02-27 Canada's pharmaceutical products industry stands out strong during recession 0 None
2010-02-27 Midlothian Laboratories donates more than $3M worth of vitamins, nutritional supplements to AmeriCares 0 None
2010-02-27 Shire receives marketing approval from FDA for VPRIV 0 None
2010-02-27 Dabigatran as effective as warfarin in preventing subsequent strokes among atrial fibrillation patients 0 5
2010-02-27 Cancer researchers assess PCI-32765 drug that targets molecular abnormalities of lymphoma cells 0 None
2010-02-27 Prevention of recurrent strokes: Antiplatelet drug cilostazol effective and safer than aspirin 0 5
2010-02-26 Gaucher disease: FDA approves VPRIV 0 None
2010-02-26 Wound Management Technologies announces recent increase in sales of CellerateRx throughout U.S. 0 None
2010-02-26 Vion Pharmaceuticals' Onrigin SPA: FDA responds 0 None
2010-02-26 Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date 0 None
2010-02-26 Prevention of heart attacks: Resveratrol appears to exhibit broader action than aspirin 0 None
2010-02-26 Possible damage to children caused by compulsory vaccines: CVS calls for investigation of federal agencies 0 None
2010-02-26 Rapid, multiplexed genotyping method to identify SNPs that affect warfarin dose developed 0 None
2010-02-26 Go4Europe conference to focus on current situation of pharmaceutical companies 0 None
2010-02-26 Study identifies risk factors for vitamin D deficiency in kidney disease patients on dialysis 0 None
2010-02-26 New dietary supplement blocks triggering mechanism causing breast cell mutations 0 None
2010-02-26 USPTO issues notice of allowance for Vanda Pharmaceuticals' Fanapt long-acting injectable formulation 0 None
2010-02-25 Scientists identify new way to treat castrate resistant cells in prostate cancer patients 0 2
2010-02-25 E. Fougera receives first generic approval for Imiquimod Cream 5% 0 None
2010-02-25 FDA sets new PDUFA action date for exenatide once weekly NDA 0 None
2010-02-25 Sales revenue from Labopharm's once-daily tramadol increases to $4.7M for fourth-quarter fiscal 2009 0 None
2010-02-25 Dangers of steroid abuse: gone live 0 None
2010-02-25 Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases 0 None
2010-02-25 FEHBP's H.R. 4489 overhaul will undermine cost-saving tools and disrupt prescription drug benefits 1 None
2010-02-25 Myeloma Canada calls on Quebec government to approve Revlimid as second-line therapy 2 5
2010-02-25 Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production 0 None
2010-02-25 Signaling molecules may link certain actions of B cells to solid tumor growth: Study 0 5
2010-02-25 American Lung Association supports ACIP's recommendations for universal influenza immunization 0 None
2010-02-25 Low doses of lasofoxifene reduce all common problems in postmenopausal women: Study 0 None
2010-02-25 Orexo partner submits NDA for cancer pain drug Abstral in Japan 0 None
2010-02-25 Rapamycin may hold promise for Alzheimer's disease 0 None
2010-02-25 GlaxoSmithKline responds to Staff Report on GlaxoSmithKline and the Diabetes Drug Avandia 0 None
2010-02-25 New data shows Valortim antibody enhances human T cell response to B. anthracis 0 None
2010-02-25 Nevirapine taken to protect fetus from HIV should be avoided for one year after childbirth, say researchers 0 None
2010-02-25 Inverseon comments on LABAs and INV102CR drugs 0 None
2010-02-25 Advanced ovarian cancer: Avastin-chemotherapy combination followed by Avastin alone improves PFS 0 None
2010-02-25 High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study 0 None
2010-02-25 EpiCept provides business update and fourth-quarter financial highlights 0 None
2010-02-25 SSRIs exhibit anti-inflammatory effects and may provide drug development opportunities for RA 0 None
2010-02-25 Genetic Disorder Tracker introduced by Guidepoint Global 0 None
2010-02-25 FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine 0 None
2010-02-24 Unique technology identifies drug candidates, speeds up drug development 0 None
2010-02-24 FDA approves Wyeth Pharmaceuticals' Prevnar 13 pneumococcal disease vaccine 0 None
2010-02-24 FDA accepts Arena Pharmaceuticals' lorcaserin NDA 0 None
2010-02-24 Shire receives FDA Fast Track designation for REPLAGAL 0 None
2010-02-24 Nutrition 21: Health Canada approves chromium picolinate for sale as a natural health product 0 None
2010-02-24 FDA's warning over LABA medications for asthma: AANMA offers guidance 0 None
2010-02-24 PharmAthene awarded total of $78.4M in additional funding to develop SparVax vaccine 0 None
2010-02-24 ONDCP, HHS announce availability of over $1.1M for new Drug Free Communities Support programs 0 4
2010-02-24 Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S 0 None
2010-02-24 Emerging oral atypical antipsychotics to compete in increasingly crowded schizophrenia drug market 0 None
2010-02-24 Sentry BioPharma Services to warehouse and distribute influenza vaccines for CDC 0 None
2010-02-24 Joint science advisory issues messages for diabetics at risk for heart disease and stroke 0 5
2010-02-24 FEHBP PBM contracts: HR 4489 to reduce fraud and grant OPM greater power to audit 0 None
2010-02-24 UK pharmacists overwhelmingly prefer dispensing preservative-free drugs 0 None
2010-02-24 FDA recommends H1N1 for inclusion in next year's flu vaccine 0 None
2010-02-24 Genetic link between schizophrenia and autism may help study effectiveness of drugs for both illnesses 0 None
2010-02-24 Poniard Pharmaceuticals enters into $20M committed equity financing facility with Commerce Court Small Cap Value Fund 0 None
2010-02-24 FDA: Invirase-Norvir combination therapy for HIV may adversely affect the heart 0 None
2010-02-24 ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI 0 5
2010-02-24 Recreational drugs can trigger memory lapse 0 None
2010-02-24 Prednisolone associated with recurrence of CAP after its withdrawal 0 None
2010-02-24 WuXi PharmaTech's Shanghai c-GMP manufacturing facility receives MPA compliance certificate 0 None
2010-02-24 Clout of drug industry seen in MD residency programs and in health reform 0 None
2010-02-23 Forest Laboratories' Bystolic tablets for treatment of stable CHF failed to receive FDA approval 0 None
2010-02-23 FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE 0 3
2010-02-23 NASDAQ halts trading of Salix Pharmaceuticals stock, FDA Committee to discuss XIFAXAN NDA 0 None
2010-02-23 Health Canada approves GARDASIL for prevention of genital warts in males 0 3
2010-02-23 NCC, Pfizer provide over 10M units of ReFacto Antihemophilic Factor to underserved hemophilia patients 0 None
2010-02-23 Gross sales of Acorda Therapeutics' ZANAFLEX CAPSULES and tablets increase 9.1% to $58.3M in 2009 0 None
2010-02-23 ExonHit Therapeutics includes proprietary lead compounds into collaboration with Allergan 0 None
2010-02-23 FDA issues approval for Gileads's Cayston for respiratory symptoms in cystic fibrosis 0 None
2010-02-23 Obecure granted patent covering betahistine with olanzapine for mitigating antipsychotic drug associated weight gain 0 None
2010-02-23 Study shows CEL-2000 vaccine blocks RA progression in mice 0 None
2010-02-23 FDA grants Haemonetics clearance to collect two RBC on Cymbal system 0 None
2010-02-23 DURECT, Nycomed amend POSIDUR Development and License Agreement 0 None
2010-02-23 Star Scientific seeks FDA marketing approval for Ariva-BDL dissolvable tobacco lozenge 0 5
2010-02-23 Eon Labs to pay $3.5M for resolving False Claims Act allegations concerning Nitroglycerin SR capsules 0 5
2010-02-23 Watson Laboratories files ANDA for generic Aplenzin ER in treatment of major depressive disorder 0 None
2010-02-23 Senate, FDA reports increasing concerns about controversial diabetes drug 0 None
2010-02-23 AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps 0 None
2010-02-22 Chiltern International and Charles River Laboratories to study radiolabelled drug products 0 None
2010-02-22 Ritter Pharmaceuticals to discuss lactose intolerance and associated health risks at NIH Conference 0 None
2010-02-22 BioSante Pharmaceuticals' ongoing LibiGel Phase III clinical development program: Additional positive data 0 None
2010-02-22 Gilead Sciences receives FDA approval for new inhaled antibiotic in treatment of CF 0 None
2010-02-22 Boehringer Ingelheim Pharmaceuticals receives FDA approval for Mirapex ER in treatment of early PD 0 None
2010-02-22 Genetics associated with DILI and SSR: FDA and SAEC complete third release of data 0 None
2010-02-22 Cancer pain patients: European regulations restricting access to opioid-based drugs 0 4
2010-02-20 Missing prescription drugs: Cardinal Health Pharmacy Services to pay $1M penalty 0 4
2010-02-20 News outlets examine HIV vaccine research, cervical cancer screening data presented at conference 0 None
2010-02-20 Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date 0 None
2010-02-19 Janssen-Cilag International's European MAA for ZEFTERA: CHMP adopts negative opinion 0 None
2010-02-19 Passage of DSSA will restrict Americans’ access to nutritional supplements, says Hotze Enterprises 1 5
2010-02-19 GenVec announces new contract with DHS to develop adenovector-based vaccines against FMD 0 None
2010-02-19 United Therapeutics announces withdrawal of Tyvaso European MAA for treatment of PAH 0 None
2010-02-19 Depomed receives final meeting minutes from FDA for pre-NDA meeting on DM-1796 for PHN 0 None
2010-02-19 BioTrends' Stelara second wave report finds increase in prescribing among dermatologists 0 None
2010-02-19 Parker Waichman Alonso applauds GSK for deciding to stop manufacturing denture adhesive products made with zinc 0 None
2010-02-19 State policy developments: Wisconsin's new 'public option,' Iowa's medical marijuana vote, and more 0 None
2010-02-19 Cancer patients frequently face barriers to accessing oral drugs: Study 0 None
2010-02-19 Delay in Vibativ's approval for nosocomial pneumonia to reduce previously forecasted commercial impact 0 None
2010-02-19 New Jersey Superior Court links Roche's Accutane to IBD 0 5
2010-02-19 DSM Pharmaceutical Products wins Profiles in Sustainability award 0 None
2010-02-19 Proven strategies mastered by best-in-class biopharma companies 0 None
2010-02-19 FDA approves 53 new cancer indications between July 2005 and end of 2007 0 None
2010-02-19 UBC researcher finds improved uptake of highly active antiretroviral therapy 0 None
2010-02-19 Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML 0 None
2010-02-19 Researchers develop technology to preserve vaccines in tropical temperatures 1 None
2010-02-19 Pharmaceutical and biotechnology companies working on nearly 200 new medicines to treat diabetes 0 None
2010-02-19 GSK decides to remove potentially hazardous zinc from denture adhesive products 0 None
2010-02-19 VARI researchers find ways to reverse resistance to sunitinib: Patients with ccRCC show positive response 0 None
2010-02-19 Valensa International enters into license agreement with Biova for BiovaFlex ingredient 0 None
2010-02-19 Report examines how medical technology changes state of health care 0 None
2010-02-19 FDA's proposed label changes for LABA asthma medications: GSK reviews 0 None
2010-02-19 Asthma: LABAs should not be used alone 0 None
2010-02-19 FDA accepts filing of Jazz Pharmaceuticals' NDA for sodium oxybate 0 None
2010-02-18 Lower dose of avosentan drug may provide more favorable results in diabetes patients 0 None
2010-02-18 FDA approves Rituxan-FC combination therapy for CLL 0 None
2010-02-18 GeoVax Labs presents results of preclinical study on prototype HIV/AIDS vaccine at CROI 0 None
2010-02-18 Rituxan, intended for patients with CLL receives FDA approval 0 None
2010-02-18 OPKO Health acquires Pharmacos Exakta 0 None
2010-02-18 Medline Industries signs exclusive distribution agreement with Derma Sciences for BIOGUARD Barrier Dressings 0 None
2010-02-18 NPG becomes official media partner to the 2010 WIN Symposium 0 None
2010-02-18 Patient-centered medical home concept to benefit pharmaceutical industry 0 None
2010-02-18 Combination therapy that delays nursing home admission for AD earns 43% patient share in U.S. and 30% in Europe 0 None
2010-02-18 Catalyst Pharmaceutical Partners to present overview of CPP-115 compound at epilepsy conference 0 None
2010-02-18 Aptuit develops proprietary production screen to understand API and drug formulations 0 None
2010-02-18 Study demonstrates once-a-week TB drug is as effective as daily dose 0 None
2010-02-18 Anti-seizure medication prevents seizures in patients following bleeding stroke: Study 0 2.7
2010-02-18 Medication therapy management programs for Aetna Medicare members 0 None
2010-02-18 Cannabis promising for certain pain-related medical conditions, CMCR presents findings to California legislature 0 5
2010-02-18 FDA issues Complete Response Letter for Horizant in treatment of RLS 0 None
2010-02-18 Taking zinc supplements reduces otitis media in healthy children: No clear evidence 0 None
2010-02-18 FDA warns about drug mix-ups; drug maker agrees to name change to avoid confusion 0 None
2010-02-18 Ibuprofen may reduce risk of Parkinson's disease, says study 0 None
2010-02-18 Media examine fight against counterfeit drugs 0 None
2010-02-18 Javelin Pharmaceuticals’ Dyloject NDA receives FDA PDUFA date 0 None
2010-02-17 Sorafenib drug therapy can reduce the size of primary kidney tumors before surgery 0 None
2010-02-17 Top health groups increased political spending in 2009 0 None
2010-02-17 Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency 0 None
2010-02-17 IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation 0 None
2010-02-17 Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances 0 None
2010-02-17 Menopause supplement to bring body back into balance 0 None
2010-02-17 FDA approved cannabis medicines needed for veterans to relieve symptoms of PTSD 1 5
2010-02-17 Soligenix' LPM oral drug delivery technology receives Hong Kong patent 0 None
2010-02-17 Cipher Pharmaceuticals announces fourth-quarter and fiscal year 2009 results 0 None
2010-02-17 UKONS publishes position statement on safe, effective use of oral anticancer medicines 0 None
2010-02-17 AHF to protest Merck’s Isentress pricing and policies at CROI 0 None
2010-02-17 AMAG's Feraheme use on the rise 0 None
2010-02-17 New book by 12 world-leading scientists calls for renewed approach to drug policy 0 None
2010-02-17 Belatacept costimulation blocker can prevent rejection of new organs by the immune system 0 None
2010-02-17 Research suggests scorpion venom could be an alternative to morphine painkiller 3 5
2010-02-17 Effectiveness of influenza vaccines in older people: No clear conclusions 0 5
2010-02-17 Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine 1 None
2010-02-17 Researchers use new strategy to develop cancer vaccines 0 None
2010-02-17 ECR Pharmaceuticals to promote Urocit-K 15mEq tablets to primary care physicians 0 None
2010-02-17 Covidien's Exalgo NDA: FDA sets new PDUFA action date 0 5
2010-02-17 Covidien, IAE POLATOM announce agreement to augment supply of Mo 99 to produce Tc 99m 0 None
2010-02-17 FDA approves risk management program on ESA's for treating anemia due to chemotherapy 0 1
2010-02-17 USPTO issues two new patents for EKR Therapeutics' RTU Cardene I.V. Premixed Injection 0 None
2010-02-17 AZ&Me Prescription Savings programs help 13% more patients in 2009 0 None
2010-02-17 APCER PHARMA to demonstrate pharmacovigilance/drug safety and regulatory services at GPhA meeting 0 None
2010-02-17 Adding daclizumab to standard treatment reduces enlarged brain lesions in patients with relapsing MS 0 None
2010-02-17 Combination of daclizumab and interferon beta significantly reduces MS lesion formation 0 None
2010-02-17 NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley 0 None
2010-02-17 Bedford Laboratories launches Indomethacin for Injection 0 None
2010-02-17 CMAJ study: Increased dosage of Tamiflu required in treating H1N1 influenza patients 0 None
2010-02-17 Amgen and Centocor Ortho Biotech Products: FDA approves REMS for Aranesp, EPOGEN and PROCRIT ESAs 0 None
2010-02-17 Quark Pharmaceuticals' QPI-1002 receives orphan drug designation from FDA 0 None
2010-02-17 Embera NeuroTherapeutics establishes clinical development partnership for its cocaine dependence program 0 None
2010-02-17 TopoTarget pays Celldex Therapeutics $3M sublicense income over Belinostat co-development agreement 0 None
2010-02-16 FDA extends CombinatoRx' Exalgo tablets NDA PDUFA review date 0 None
2010-02-16 EntreMed's ENMD-2076 for AML receives FDA's orphan drug designation 0 None
2010-02-16 BUSACC hosts breakfast panel over reconstruction opportunities in Iraq, covering healthcare and pharma 0 None
2010-02-16 Meda publishes 2009 year-end report 0 None
2010-02-16 VPCI pioneers on-demand GMP consultation services for Pharmaceutical manufacturers 0 None
2010-02-16 Overall benefits of HPV vaccination or frequent screening are low for women over 41 0 None
2010-02-16 When blood sugar levels rise in healthy people, insulin signals cells to increase production: Study 0 None
2010-02-16 AstraZeneca, Rigel Pharmaceuticals announce exclusive worldwide license agreement for R788 0 None
2010-02-16 Three Dutch life-science sectors announce joint investment to research on personalized medicine 0 None
2010-02-16 Use of non-steroidal anti-inflammatory drugs not associated with risk of squamous cell skin cancer 0 None
2010-02-16 Researchers discover chemical compound to combat malaria and bacterial diseases 0 None
2010-02-16 Teva Pharmaceuticals USA settles famciclovir patent litigation with Novartis 0 None
2010-02-16 Albemarle, Pharmacore partner to provide manufacturing capabilities for high volume capacity projects 0 None
2010-02-16 Sinovac Beijing expands production capacity with acquisition of buildings and land use rights in Changping 0 None
2010-02-15 Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese 0 None
2010-02-15 ERYtech Pharma announces collaborative research agreement with M. D. Anderson Cancer Center 0 None
2010-02-15 Botulinum injection used for cosmetic purposes may reduce migraine headaches 0 None
2010-02-15 Research findings may open door to new therapeutic strategies for serious health problems 0 None
2010-02-15 Isogenica enters into agreement with Dstl to develop antimicrobial peptide drugs 0 4
2010-02-15 Walgreens Pharmacies postpones withdrawal from Washington Medicaid program 0 None
2010-02-15 Antibiotics program of Giant Eagle results in more than $3M in free prescriptions for customers 0 None
2010-02-15 Wyoming lawkmaker pushes for reform, Mississippi Governor bans certain over-the-counter drugs 0 None
2010-02-12 U.S. Court rules in favor of Perrigo over Mucinex patent litigation 0 5
2010-02-12 Rate of seasonal flu vaccination doubles national average at Johns Hopkins East Baltimore medical campus 0 None
2010-02-12 Treating bacteria with insufficient levels of antibiotics leads to multidrug resistance in 'superbugs' 0 None
2010-02-12 New pain management options for patients undergoing knee or hip replacements 0 None
2010-02-12 Data demonstrates the effectiveness of NeuroAiD on neuronal and brain injuries 0 None
2010-02-12 Glycotex announces the expansion of patent portfolio in Advanced Wound Healing for GLYC-101 0 None
2010-02-12 Researchers develop dietary supplement to offset key symptom of ageing 0 2.5
2010-02-12 Sun Knowledge to attend Annual Drug Benefit Conference in Phoenix 0 5
2010-02-12 Low doses of antibiotics may serve as active mutagens and lead to multidrug resistance 0 None
2010-02-12 Sustamine L-Alanyl-L-Glutamine supplement increases performance in endurance exercise and activity 0 None
2010-02-12 Proving value a challenge for comparative effectiveness and pharmaceutical technologies 0 None
2010-02-12 Sales of Cobroxin exceeds XenaCare Holdings' projections for first 45 days of 2010 0 None
2010-02-12 Ulcerative colitis drug market to grow up to $2.1 billion in 2018 0 None
2010-02-12 Researchers identify potential drug candidate that halts tumor growth 0 None
2010-02-12 Cancer drug could be effective for treating recurrent nose bleeds 0 None
2010-02-12 Scientists find single-dose of drug cures visceral leishmaniasis 0 None
2010-02-12 Biological-based therapies are alternative medicines for women recovering from breast cancer 0 None
2010-02-11 FDA grants approval for Abbott's antiretroviral medication Norvir 0 None
2010-02-11 Daiichi Sankyo's Benicar receives FDA approval for hypertension treatment in children and adolescents aged 6-16 0 None
2010-02-11 Cadence Pharmaceuticals' IV acetaminophen NDA receives FDA Complete Response letter 0 None
2010-02-11 Simcere Pharmaceutical Group subsidiary receives Chinese SFDA approval for Zanamivir 0 None
2010-02-11 Indiana's pharmaceutical research and manufacturing companies maintained steady growth in 2009 0 None
2010-02-11 Micromet outlines the design of registration study for blinatumomab in ALL 0 None
2010-02-11 Shenogen Pharma Group, Chemizon sign drug discovery collaboration agreement 0 None
2010-02-11 CINJ researchers develop new vaccine strategy for pancreatic cancer 0 None
2010-02-10 Drug used to treat parasites in animals may offer new treatment for river blindness, study finds 0 None
2010-02-10 TZD drug may increase fracture risk in older women 0 None
2010-02-10 AVANIR Pharmaceuticals receives patent for low-dose quinidine formulations of Zenvia to treat PBA 0 None
2010-02-10 Psoriasis drug Enbrel to account for less than one-fifth of sales in 2018 overall market 0 None
2010-02-10 Medicinal chemistry paper related to the discovery of CUDC-101 published 0 None
2010-02-10 Study shows more women die of heart disease each year than men 1 None
2010-02-10 Majority of parents worry about safety of H1N1 vaccine 0 None
2010-02-10 Avrio Biopharmaceuticals receives Cal FDB approval to manufacture and ship pharmaceutical products 0 None
2010-02-10 Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug 0 None
2010-02-10 Glissandra Skincare signs first distribution agreement with Enchanted Meadow 0 5
2010-02-10 Pivotal Research to study investigational drug for menstrual cramps 0 None
2010-02-10 New method may help assess impact and cost-effectiveness of flu vaccination campaigns 0 None
2010-02-10 New research suggests closantel drug may be useful in combating river blindness 0 None
2010-02-10 Future studies may provide clarity on the best approach for pre-surgery beta blockers 0 None
2010-02-10 Breast cancer patients taking antidepressant paroxetine at the same time as tamoxifen are at increased risk of death 1 None
2010-02-10 Huntington's disease: Latrepirdine appears well-tolerated and beneficial 0 1
2010-02-10 VSV has potential to be genetically modified to serve as anti-cancer agent 0 5
2010-02-10 Soy isoflavone tablet does not prevent bone loss in postmenopausal women 0 None
2010-02-10 Antimalarial medicines in African countries are substandard, says QAMSA study 0 None
2010-02-10 Measles vaccine does not increase risk of autism in children, reveals Polish study 0 None
2010-02-10 Researchers publish findings that may lead to new standard of care for cervical cancer patients 0 None
2010-02-10 Cholesterol lowering drugs also reduce risk of developing cataracts 0 5
2010-02-10 Dana-Farber Cancer Institute, Sanford-Burnham Medical Research Institute sign license agreement with Genentech, Roche 0 None
2010-02-10 Findings of poor quality malaria drugs in Africa add to artemisinin-resistance worries 0 None
2010-02-10 MSU launches research and training program to address product counterfeiting 0 None
2010-02-10 Research opens door for advancement of new category of painkillers 0 None
2010-02-10 USPTO awards Transcept Pharmaceuticals patent covering Intermezzo's composition and usage method 0 None
2010-02-10 GA²LEN and EAACI warn: Older antihistamines in OTC allergy medications may be hazardous 0 None
2010-02-10 Excelsior Medical receives Canadian marketing license for new, pre-filled catheter lock syringe 0 None
2010-02-10 FDA expands indication for Crestor 0 None
2010-02-09 Morphologi G3 adds new dimension to Solvay Pharmaceuticals R&D 0 None
2010-02-09 Survey reveals need for better access to levalbuterol for asthma patients 0 None
2010-02-09 Regence introduces new solution that covers all medications under single medication benefit 0 None
2010-02-09 Cell Therapeutics' pixantrone NDA: FDA postpones ODAC meeting due to severe weather conditions 0 None
2010-02-09 Merck's asthma drug formoterol/mometasone to garner global peak year sales of more than $250M 0 None
2010-02-09 FDA accepts Psyadon Pharmaceuticals' ecopipam IND for treatment of LND 0 1
2010-02-09 Glaucoma medications appear to reduce mortality risk 0 None
2010-02-09 Study indicates pain treatment may vary in Latino and white children post surgery 0 None
2010-02-09 FDA approves Lupin Pharmaceuticals' Amlodipine/Benazepril capsules 0 None
2010-02-09 FDA approves Sagent Pharmaceuticals' labetalol HCl injection for severe hypertension 0 None
2010-02-09 Dimebon drug associated with improved cognitive function in patients with Huntington's disease 0 None
2010-02-09 Kamada commences enrollment in European inhaled AAT clinical trial for alpha-1 antitrypsin deficiency 1 4
2010-02-08 Hospitals selling uninsured drugs may negatively impact public system 0 None
2010-02-08 FDA approves Amneal Pharmaceuticals' Tramadol/APAP tablets 1 None
2010-02-08 Repros Therapeutics submits Androxal revised indication statement to the FDA 0 None
2010-02-08 3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience 0 None
2010-02-08 LPC Pharma Group outsources pharmacovigilance/drug safety operations to APCER Pharma 0 None
2010-02-08 Novavax to discontinue collaboration agreement with ROVI Pharmaceuticals 0 None
2010-02-08 Researchers find low prevalence of tamoxifen use for prevention of breast cancer among women 0 None
2010-02-07 Investigational drug for osteoporosis inhibits serotonin synthesis in the gut 0 5
2010-02-06 URAC seeks public input for Pharmacy Quality Management Accreditation programs 0 None
2010-02-06 Combination of Motrin and Robitussin drugs is safe for adults and children 2 4.8
2010-02-06 HPV vaccination programs may reduce genital diseases 0 None
2010-02-06 Teva Pharmaceutical Industries reaches settlement in principle to resolve claims under federal, state False Claims Acts 0 None
2010-02-06 AMAG Pharmaceuticals releases safety update on Feraheme Injection 0 None
2010-02-06 State policy developments: Iowa seeks to extend birth control coverage; Minn. eyes more health care for poor; Miss. drug settlement 0 None
2010-02-06 Health bill stall creates uncertainty for drug makers 0 None
2010-02-06 Strativa Pharmaceuticals' Zuplenz NDA: FDA issues complete response letter 0 None
2010-02-05 FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency 0 None
2010-02-05 BioTime announces results of independent Hextend study in hemodynamically unstable trauma patients 0 None
2010-02-05 Pharma IQ to organize 4th Improving Solubility conference at The Park Hyatt in Philadelphia 0 None
2010-02-05 'Doctor Shopping': Data from California's prescription monitoring program 0 None
2010-02-05 New ICD-9-CM database provides FDA-approved and off-label uses for therapeutic drugs 0 None
2010-02-05 Emerson Ecologics officially launches Emerson Quality Program 0 None
2010-02-05 Pazopanib drug slows the progression of RCC in patients by 54% 0 None
2010-02-05 New report finds low adult vaccination rates in U.S. 0 None
2010-02-05 Mylan first to file ANDA patent for Caduet Tablets 0 None
2010-02-05 Report shows more Americans are buying prescription drugs to treat digestive conditions 0 None
2010-02-05 Elephantiasis and river blindness: MSU researcher receives $2M for reformulating flubendazole 0 None
2010-02-05 New class of compound could become effective antidepressant with minimal side effects 0 None
2010-02-05 Early stage trial finds malaria vaccine effectively protected young children, study says 0 None
2010-02-05 Children exposed to acetaminophen prenatally more likely to have asthma symptoms at age five 0 None
2010-02-05 Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM 0 5
2010-02-05 Lux Biosciences seeks US and European marketing approval for LUVENIQ 0 None
2010-02-04 Progenics Pharmaceuticals to present preclinical data of multiplex PI3K inhibitors 0 None
2010-02-04 Lux Biosciences files NDA with FDA and MAA with EMA for approval of voclosporin 0 None
2010-02-04 TenX Biopharma acquires exclusive global rights to zanolimumab from Genmab 0 None
2010-02-04 Alkermes develops proprietary LinkeRx technology platform to create injectable antipsychotics 0 3
2010-02-04 "Knowledge deficit" about methadone responsible for resulting deaths 0 None
2010-02-04 Expert available to discuss Lancet’s retraction of paper on autism study 0 None
2010-02-04 Phase Forward to participate in DIA Workshop and Clinical Trial Supply event 0 None
2010-02-04 February issue of Chest releases latest medical news 0 None
2010-02-04 Discussion on IATA Chapter 17 compliance for temperature-sensitive products at 8th Cold Chain Summit 0 None
2010-02-04 Health Canada accepts AbstralTM New Drug Submission for review 0 None
2010-02-04 Paracetamol reduces damage caused to kidneys following severe muscle injury 1 1
2010-02-04 Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys' summer camp 0 None
2010-02-04 Sermo announces a new report on evolving trends in CML 0 None
2010-02-04 New discovery lays foundation for development of new anti-HIV drugs 0 None
2010-02-04 EUCODIS Bioscience to utilize EUR 2M capital injection for adding enzyme families and development of international markets 0 None
2010-02-04 CRN issues statement on "The Dietary Supplement Safety Act of 2010" 1 None
2010-02-04 Ipsen launches Decapeptyl LP 22.5 mg in France 0 None
2010-02-04 Vaccination against seasonal influenza produces protective immune response in infants 0 None
2010-02-04 FDA approves Xiaflex drug for treatment of Dupuytren's contracture 5 3.3
2010-02-04 Study: Generic nifedipine product not bioequivalent to Adalat XL 0 5
2010-02-04 National consensus reached on Joint Technical Statement for drug products 0 None
2010-02-04 Repligen receives USPTO Notice of Allowance for patent covering a recombinant form of Protein A 0 None
2010-02-04 New vaccine to prevent malaria infection shown promise to protect young children 0 None
2010-02-03 New York Times examines WHO process for getting H1N1 vaccines to countries in need 0 None
2010-02-03 Study shows Cymbalta reduces chronic low back pain 1 5
2010-02-03 FDA approves Labopharm's OLEPTRO antidepressant for MDD 0 None
2010-02-03 Drug company CEOs under pressure 0 None
2010-02-03 AMPYRA for MS: Acorda Therapeutics announces wholesale pricing and patient assistance program 14 5
2010-02-03 Louisiana residents can now save money with free prescription drug cards 0 None
2010-02-03 New weight-loss supplement burns calories 0 None
2010-02-03 Research retraction underscores the safety and efficacy of MMR vaccines 0 None
2010-02-03 Study linking autism and vaccines is retracted by medical journal 0 None
2010-02-03 Hundred millions for biotech-licence 0 None
2010-02-03 Hypertension drug market to decrease through 2013 due to generic erosion and few emerging therapies 0 1.5
2010-02-03 Tips to prevent heartburn 0 None
2010-02-03 CPS supports NACI recommendations for new shingles vaccine 0 None
2010-02-03 BioSpecifics Technologies' XIAFLEX receives FDA approval 2 None
2010-02-03 PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world 0 None
2010-02-03 Upsher-Smith Laboratories introduces new formulation of PreNexa Rx prenatal vitamins 0 None
2010-02-03 Artefill could be viable for lipoatrophy and non-surgical anti-aging enhancement 0 None
2010-02-03 VIDAZA prolongs survival in AML patients 5 4
2010-02-03 Sales of Nutra Pharma's Cobroxin totaled $583,955 for fourth-quarter ending December 31, 2009 0 None
2010-02-02 Lannett Company plans to submit NDA for Morphine Sulfate products to FDA 0 None
2010-02-02 Hovione announces filing of new drug application in Japan for the influenza drug CS-8958 0 None
2010-02-02 FDA accepts Teva Pharmaceutical Industries' BLA for XM02 G-CSF 0 None
2010-02-02 Javelin Pharmaceuticals' NDA for Dyloject Injection accepted for formal review 0 5
2010-02-02 FDA approves INNOPHARMA's ibutilide fumarate injection ANDA 0 None
2010-02-02 Xiaflex receives FDA approval for treatment of Dupuytren's contracture 1 5
2010-02-02 FDA approves Taro Pharmaceutical Industries' levetiracetam tablets ANDA 0 None
2010-02-02 Cytheris broadens patent protection for recombinant human interleukin-7 0 5
2010-02-02 Spectrum Pharmaceuticals signs co-development and commercialization agreement with TopoTarget A/S 0 None
2010-02-02 FDA requests additional data on CMC section of NDA for taliglucerase alfa from Protalix BioTherapeutics 0 None
2010-02-02 Extended nicotine patch therapy benefits relapsing smokers trying to quit 0 5
2010-02-02 First annual Translational Regenerative Medicine Forum to be held in Winston-Salem 0 5
2010-02-02 Suzhou Erye Pharmaceutical receives Chinese SFDA approval for manufacturing penicillin at new facility 0 None
2010-02-02 New therapeutic made from tobacco plants shown to arrest West Nile virus infection 0 None
2010-02-02 ADT can worsen heart risk factors and may increase the risk of heart attack 0 None
2010-02-02 SDI selected for third consecutive time as key monoclonal antibody provider 0 None
2010-02-02 Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical 0 None
2010-02-02 Decision Resources: Benlysta to garner more than $500M in 2018 0 2
2010-02-02 Some states mull requiring prescription for meth ingredients 0 None
2010-02-02 BRI partners with French Government to create therapeutic antibodies for treatment of major diseases 0 None
2010-02-02 FDA and PATH collaborate to advance pneumococcal vaccine development for children 0 None
2010-02-02 Long-chain omega-3 polyunsaturated fatty acids may reduce risk of psychotic disorders 0 None
2010-02-02 Serious liver disorder associated with use of HIV drug, FDA warns 0 None
2010-02-02 Researchers identify antiviral small molecule that is effective against numerous viruses 0 None
2010-02-02 Evidence suggests antidepressants may improve post-stroke recovery 0 None
2010-02-02 Shire announces the Canadian availability of VYVANSE prodrug therapy for ADHD treatment 1 None
2010-02-01 Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds 0 None
2010-02-01 TOPICA's IND for onychomycosis antifungal agent accepted by FDA 0 None
2010-02-01 FDA approves Allergan's JUVÉDERM XC dermal filler 0 None
2010-02-01 Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11 0 None
2010-02-01 Ipsen reports consolidated group sales of €1,032.8M for 2009 0 None


367 posts
92 raters